Autologous Hematopoietic Cell Transplantation For Relapsed Multiple Myeloma Performed With Stem Cells Re-Mobilised Following A Prior AUTO-HCT - A Retrospective Study on Behalf of EBMT CMWP

被引：0
|
作者：
Drozd-Sokolowska, Joanna [1 ]
Gras, Luuk [2 ]
Zinger, Nienke [3 ]
Snowden, John A. [4 ]
Arat, Mutlu [5 ]
Basak, Grzegorz [1 ]
Pouli, Anastasia [6 ]
Crawley, Charles [7 ]
Wilson, Keith M. O. [8 ]
Tilly, Herve [9 ]
Byrne, Jennifer [10 ]
Bulabois, Claude Eric [11 ]
Passweg, Jakob [12 ]
Ozkurt, Zubeyde Nur [13 ]
Schroyens, Wilfried [14 ]
Lioure, Bruno [15 ]
Colorado Araujo, Mercedes [16 ]
Poire, Xavier [17 ]
Van Gorkom, Gwendolyn [18 ]
Gurman, Gunhan [19 ]
de Wreede, Liesbeth [20 ]
Hayden, Patrick [21 ]
Beksac, Meral [19 ]
Schoenland, Stefan [22 ]
Yakoub-Agha, Ibrahim [23 ]
机构：
[1] Med Univ Warsaw, Warsaw, Poland
[2] EBMT Stat Unit Data Off, Leiden, Netherlands
[3] EBMT Data Off, Leiden, Netherlands
[4] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England
[5] Florence Nightingale Sisli Hosp, Istanbul, Turkey
[6] Haematol Dept, Athens, Greece
[7] Addenbrookes Hosp, Cambridge, England
[8] Dept Haematol, Cardiff, S Glam, Wales
[9] Ctr Henri Becquerel, Rouen, France
[10] Univ Nottingham, Nottingham, England
[11] Univ Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France
[12] Univ Hosp, Basel, Switzerland
[13] Gazi Univ, Fac Med, Ankara, Turkey
[14] Antwerp Univ Hosp UZA, Antwerp, Belgium
[15] Tech Etud Clin Suivi Patients Greffes, Strasbourg, France
[16] Hosp Univ Marques de Valdecilla, Santander, Spain
[17] Clin Univ St Luc, Brussels, Belgium
[18] Univ Hosp Maastricht, Maastricht, Netherlands
[19] Ankara Univ, Fac Med, Ankara, Turkey
[20] Leiden Univ, Med Ctr, Leiden, Netherlands
[21] Trinity Coll Dublin, St Jamess Hosp, Dublin, Ireland
[22] Heidelberg Univ, Med Klin & Poliklin 5, Heidelberg, Germany
[23] Univ Lille, CHU Lille, INSERM, U1286, Lille, France
来源：
BONE MARROW TRANSPLANTATION | 2021年 / 56卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O123
引用
收藏
页码：133 / 134
页数：2
相关论文
共 50 条
  • [31] Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT
    Giorgia Battipaglia
    Ariane Boumendil
    Myriam Labopin
    Fabio Ciceri
    Johanna Tischer
    Matthias Stelljes
    Gerhard Ehninger
    Dietrich Beelen
    Jürgen Finke
    Maria Teresa Van Lint
    Matthias Eder
    Boris Afanasyev
    Renato Fanin
    Mohamad Mohty
    Annalisa Ruggeri
    Arnon Nagler
    Bone Marrow Transplantation, 2019, 54 : 1499 - 1510
  • [32] Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT
    Battipaglia, Giorgia
    Boumendil, Ariane
    Labopin, Myriam
    Ciceri, Fabio
    Tischer, Johanna
    Stelljes, Matthias
    Ehninger, Gerhard
    Beelen, Dietrich
    Finke, Juergen
    Van Lint, Maria Teresa
    Eder, Matthias
    Afanasyev, Boris
    Fanin, Renato
    Mohty, Mohamad
    Ruggeri, Annalisa
    Nagler, Arnon
    BONE MARROW TRANSPLANTATION, 2019, 54 (09) : 1499 - 1510
  • [33] Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
    Vincent, Laure
    Gras, Luuk
    Ceballos, Patrice
    Finke, Juergen
    Passweg, Jakob
    Harel, Stephanie
    Rosinol, Laura
    Minnema, Monique
    Teipel, Raphael
    van Doesum, Jaap
    Haenel, Mathias
    Lenain, Pascal
    Botella-Garcia, Carmen
    Koenecke, Christian
    Ducastelle, Sophie
    Sanz, Jaime
    Schroyens, Wilfried
    Zuckerman, Tsila
    Monaco, Federico
    Koster, Linda
    de Wreede, Liesbeth
    Hayden, Patrick J.
    Schoenland, Stefan
    Yakoub-Agha, Ibrahim
    Beksac, Meral
    BONE MARROW TRANSPLANTATION, 2022, 57 (03) : 499 - 501
  • [34] Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
    Laure Vincent
    Luuk Gras
    Patrice Ceballos
    Jürgen Finke
    Jakob Passweg
    Stéphanie Harel
    Laura Rosinol
    Monique Minnema
    Raphael Teipel
    Jaap van Doesum
    Mathias Hänel
    Pascal Lenain
    Carmen Botella-Garcia
    Christian Koenecke
    Sophie Ducastelle
    Jaime Sanz
    Wilfried Schroyens
    Tsila Zuckerman
    Federico Monaco
    Linda Koster
    Liesbeth de Wreede
    Patrick J. Hayden
    Stefan Schönland
    Ibrahim Yakoub-Agha
    Meral Beksac
    Bone Marrow Transplantation, 2022, 57 : 499 - 501
  • [35] Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) after Autologous Hematopoietic Cell Transplantation (auto-HCT): Extended Follow-up of the Phase 2 Single-Arm CheckMate 205 Study
    Armand, Philippe
    Engert, Andreas
    Younes, Anas
    Lee, Hun Ju
    Santoro, Armando
    Zinzani, Pier Luigi
    Timmerman, John M.
    Collins, Graham P.
    Ramchandren, Radhakrishnan
    Cohen, Jonathon B.
    De Boer, Jan Paul
    Savage, Kerry J.
    Kuruvilla, John
    Trneny, Marek
    Shipp, Margaret A.
    Sacchi, Mariana
    Ansell, Anne Sumbuland Stephen M.
    Ansell, Stephen M.
    BLOOD, 2018, 132
  • [36] Effect of Obesity on Outcomes after Autologous Hematopoietic Stem Cell Transplantation (Auto HCT) for Multiple Myeloma (MM): An Analysis from the Center for International Blood and Marrow Transplant Research (CIBMTR)
    Vogl, Dan T.
    Perz, Waleska S.
    Wang, Tao
    Stadtmaucr, Edward A.
    Dispenzieri, Angela
    Milone, Gustavo
    Reece, Donna E.
    Hari, Parameswaran
    BLOOD, 2008, 112 (11) : 1145 - 1145
  • [37] AUTOLOGOUS STEM CELL TRANSPLANTATION (AUTO-SCT) IS HIGHLY EFFECTIVE IN RELAPSED NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A RETROSPECTIVE STUDY BY THE EBMT LYMPHOMA WORKING PARTY
    Akhtar, S.
    Boumendil, A.
    Finel, H.
    Masszi, T.
    Jindra, P.
    Nemet, D.
    Baurmann, H.
    Begiun, Y.
    Castagna, L.
    Ferrara, F.
    Foa, R.
    Malladi, R.
    Moraleda, J. M.
    Bloor, A.
    Salles, G.
    Meissner, J.
    Sureda, A.
    Dreger, P.
    HAEMATOLOGICA, 2016, 101 : 101 - 101
  • [38] Younger (<50 years) multiple myeloma (MM) patients (pts) treated with novel agents and autologous haematopoietic stem cell transplantation (auto-HCT) have longer overall survival than older pts (≥50 years)
    Cornelison, A. M.
    Dinh, Y.
    Ahmed, S.
    Bashir, Q.
    Shah, N.
    Parmar, S.
    Hosing, C.
    Popat, U.
    Shah, J.
    Shpall, E. J.
    Champlin, R.
    Qazilbash, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S205 - S205
  • [39] Extending Autologous Hematopoietic Stem Cell Transplantation As First Line Treatment in Multiple Myeloma Patients with Severe Renal Impairment: A Retrospective Study of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)
    Augeul-Meunier, Karine
    Caillot, Denis
    Stoppa, Anne-Marie
    Karlin, Lionel
    Benboubker, Lofti
    Maillard, Natacha
    Mohty, Mohamad
    Yakoub-Agha, Ibrahim
    Bay, Jacques-Olivier
    Bonmati, Caroline
    Bulabois, Claude-Eric
    Huynh, Anne
    Mercier, Melanie
    Frenzel, Laurent
    Avet-Loiseau, Herve
    Cornillon, Jerome
    BLOOD, 2016, 128 (22)
  • [40] Highly proliferative and functional PD-1+ and TIM-3+ T cells are transiently increased in multiple myeloma following autologous hematopoietic stem cell transplantation
    Batorov, Egor, V
    Aristova, Tatiana A.
    Pronkina, Natalia, V
    Sergeevicheva, Vera V.
    Sizikova, Svetlana A.
    Ushakova, Galina Y.
    Shevela, Ekaterina Y.
    Ostanin, Alexander A.
    Chernykh, Elena R.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 100
12345